• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Life Sciences Trends and Opportunities 2012-2015: Pharma, Diagnostics, and Research Industry Converge to Address Complex Disease Challenge Product Image

Global Life Sciences Trends and Opportunities 2012-2015: Pharma, Diagnostics, and Research Industry Converge to Address Complex Disease Challenge

  • ID: 2366459
  • December 2012
  • Region: Global
  • 69 Pages
  • Frost & Sullivan

Frost & Sullivan’s global life sciences team analyzes the impact of important changes and key trends across the total pharmaceutical/biotechnology, diagnostics, and life sciences research industries. This research deliverable captures the global life sciences trends and opportunities for the period of 2012-2015, as supported by Frost & Sullivan’s proprietary research and leading industry experts. Our global life sciences team is uniquely positioned to provide comprehensive analysis and guidance in the converging landscape. Topics include generics and biosimilars, emerging markets, pharmaceutical outsourcing, novel therapeutics, next generation diagnostics, research and development laboratories, and clinical laboratories.

Executive Summary

This research deliverable summarizes the global life sciences trends and opportunities from 2012 to 2015 as supported by Frost & Sullivan proprietary research and leading industry experts.

Life Sciences Trends and Opportunities: Executive Summary, Global, 2012-2015

1 Frost & Sullivan has identified three growth strategies implemented by pharmaceutical companies in response to industry challenges: READ MORE >

Note: Product cover images may vary from those shown

1 Executive Summary
2 Daunting Challenges for the Pharmaceutical Industry
3 Pharma’s New Growth Strategies
4 Curbing the Costs of Drug Development
5 Lean Laboratories—Doing More With Less
6 Novel Biomarker Discovery Leading to Novel Therapeutics
7 Genetic Technologies are Integral to Healthcare
8 Conclusions
9 Appendix
10 The Frost & Sullivan Story

List of Exhibits

- Life Sciences Trends and Opportunities: Executive Summary, Global, 2012-2015
- Life Sciences Trends and Opportunities: Growth Areas Now and Developing, Global, 2012-2015
- Life Sciences Trends and Opportunities: Companies to Watch, Global, 2012-2015
- Life Sciences Trends and Opportunities: Competitive Companies Tracked by Frost & Sullivan, Global, 2012
- Life Sciences Trends and Opportunities: Future Outlook for Healthcare Compared to Present, Global, 2012-2015
- Life Sciences Trends and Opportunities: Key Mergers and Acquisitions by Pharmaceutical Companies, Global, 2010-2012
- Life Sciences Trends and Opportunities: Open Innovation—Pfizer and Novartis, Global, 2011
- Life Sciences Trends and Opportunities: Open Innovation—GlaxoSmithKline and Eli Lilly, Global, 2011
- Life Sciences Trends and Opportunities: Healthcare Expenditure, Global, 2010-2020
- Life Sciences Trends and Opportunities: Co-development Models, U.S., 2012
- Non-Invasive Prenatal Testing Market: Level of Agreement that NIPT Should Replace Maternal Serum Screen, U.S., 2012
- Life Sciences Trends and Opportunities: Patent Expirations for Major Drugs, U.S., 2011-2016
- Life Sciences Trends and Opportunities: Patent Expirations for Top Biologics, U.S., 2011-2019
- Life Sciences Trends and Opportunities: Top M&A Deals, U.S., 2011-2016

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos